clinical trial · NCT06495424
Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy
Averitas Pharma, Inc.·—·active not recruiting·n = 144
Peripheral Diabetic NeuropathyPainful Diabetic NeuropathyCapsaicin 8%
brief summary
The purpose of this post-market observational study is to provide real-world evidence to support the repeated use of QUTENZA in patients with PDPN and to evaluate the potential for pain and concomitant medication use reduction.
started
Mar 14, 2025
primary completion
Mar 1, 2027
completion
Mar 1, 2027
last updated
Apr 21, 2026
official title
A Post-Market Observational Multi-Center Study to Evaluate the Effectiveness of Repeated QUTENZA Use in Adults With Painful Diabetic Peripheral Neuropathy of the Feet
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol